Agree! The exciting thing about biotechs is that they can go up (or down) precipitously and unexpectedly.
Bringing a drug to the marked is slow and laborious, especially in the most avant-garde of technologies (such as MSCs). BUT imagine the market cap of Pluri if the collaboration with Tuvia works out! One billion would be just a start (that's a 30 bagger from here).
Let the troglodyte ooze his slime (you find them on all anonymous boards).. I personally find the progress of the company VERY interesting and promising.